Vikas Lifecare Q3 FY26: Income drops, loss at ₹29.28 cr

Stock snapshot and why the disclosure matters

Vikas Lifecare Ltd was trading at ₹1.49 on Wednesday, June 24, 2026 at 08:03:50, based on the provided market snapshot. The company has been making a series of exchange disclosures around financial results, newspaper publications, and governance actions. These updates matter because they combine operational performance indicators (income, expenses, losses and EPS) with procedural compliance steps under SEBI listing rules. They also include steps that may change the company’s capital structure through a shareholder vote.

The dataset also lists an “upcoming earnings date” of August 14, 2025 for Vikas Lifecare Ltd. Separately, the text mentions a net profit of ₹-14 and revenue earned of ₹97, but it does not specify the period for these two standalone figures. Where the period is unclear, the story focuses on the detailed quarterly tables and company disclosures that carry specific dates and reporting periods.

Q3 FY26 unaudited results published in newspapers

Vikas Lifecare Limited published newspaper advertisements of its Q3 FY26 unaudited financial results in Financial Express and Jansatta on April 24-25, 2026. The results related to the quarter ended December 31, 2025. The company stated the results were approved by the Board of Directors in its meeting held on April 21, 2026, after review by the Audit Committee.

The newspaper publication and exchange filing were made under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as per the text. The company also submitted copies of these newspaper advertisements to both the National Stock Exchange of India Limited and BSE Limited on April 25, 2026.

Q3 FY26 performance: consolidated versus standalone

For Q3 FY26, the consolidated numbers in the table indicate Total Income of ₹97.76 crore and Total Expenses of ₹116.16 crore. This resulted in a Profit/(Loss) Before Tax of ₹-33.18 crore and Net Profit/(Loss) of ₹-29.28 crore. Basic and diluted EPS for the quarter was shown as ₹-0.04.

On a standalone basis for Q3 FY26, Total Income was ₹96.39 crore and Total Expenses were ₹115.16 crore. Profit/(Loss) Before Tax stood at ₹-18.76 crore and Net Profit/(Loss) at ₹-14.72 crore. Basic and diluted EPS on standalone basis was ₹-0.08.

The same table also provides Q2 FY26 consolidated figures: Total Income of ₹142.19 crore, Total Expenses of ₹148.29 crore, Profit/(Loss) Before Tax of ₹-120.08 crore and Net Profit/(Loss) of ₹-118.96 crore, with EPS of ₹0.03.

Nine-month income up to December 2025

For the nine months ended December 31, 2025, Vikas Lifecare reported Total Income of ₹465.60 crore on a consolidated basis and ₹459.49 crore on a standalone basis. The text does not provide the corresponding nine-month profit or loss figure in the same sentence, so the article does not infer it.

The company stated the financial results received a statutory auditor’s limited review. The document was digitally signed by Managing Director Sundeep Kumar Dhawan (DIN: 09508137), according to the disclosure.

Trading window updates and board meeting timeline

The dataset includes a trading window update stating that Vikas Lifecare’s trading window has been closed since October 1, 2025. The stated reason was pending finalization and disclosure of unaudited Q2 FY2026 results for the quarter ended September 30, 2025. It also notes the window would reopen 48 hours after the unaudited results are declared.

The text also mentions a board meeting originally scheduled for February 07, 2026 was postponed due to technical reasons. The agenda referenced consideration of unaudited financial results for the quarter and half-year ended September 30, 2025, along with results for the quarter and nine months ended December 31, 2025.

Postal ballot: warrants issue and authorised capital increase

Vikas Lifecare Limited issued a postal ballot notice seeking shareholder approval through remote e-voting for three resolutions. First, the proposed issuance of 61,90,62,500 convertible warrants worth ₹99.05 crore to promoters and public investors. Second, alteration of the Articles of Association to enable future capital issuance. Third, an increase in authorised share capital from ₹235 crore to ₹300 crore, stated as being to accommodate growth requirements.

These resolutions, if approved, would affect the company’s capital structure, and the authorised capital increase would create room for issuing additional equity-linked instruments.

Audited quarter data up to March 2025

The text also references a newspaper advertisement of audited financial results for the quarter and year ended March 31, 2025. In the quarter-ended table (amount in lakhs, converted here to ₹ crore), Total Income for the quarter ended March 31, 2025 was ₹150.65 crore and Net Profit/Loss was ₹0.91 crore. The table also lists earlier quarters such as December 31, 2024 with Total Income of ₹111.43 crore and Net Profit/Loss of ₹-5.16 crore.

In the board report excerpt for the financial year ended March 31, 2025, consolidated revenue from operations increased from ₹471.90 crore to ₹505.99 crore. The company reported a consolidated loss of ₹10.92 crore for the year under review, compared with a profit of ₹13.45 crore in the previous year. On a standalone basis, turnover was ₹489.90 crore versus ₹442.89 crore in the previous year, and the company reported a standalone loss of ₹2.26 crore versus a profit of ₹19.32 crore in the previous year.

Q1 FY26: income, losses and expenses trend

For Q1 FY26 (quarter ended June 2025), the text states total income of ₹95.35 crore, down 30.0% quarter-on-quarter from ₹136.27 crore in Q4 FY25, and up 1.1% year-on-year from ₹94.33 crore in Q1 FY25. Profit before tax was a loss of ₹-2.63 crore, compared with a loss of ₹-0.13 crore in Q4 FY25. Profit after tax was a loss of ₹-3.95 crore, compared with a loss of ₹-2.03 crore in Q4 FY25 and a loss of ₹-2.91 crore in Q1 FY25.

Operating expenses for Q1 FY26 were reported at ₹97.98 crore, down 24.6% from the previous quarter’s ₹130.01 crore. Tax expense for Q1 FY26 was ₹0.08 crore.

Key numbers at a glance

Market impact and what investors can track

The information flow in the dataset points to two clear market-relevant threads. One is performance, where Q3 FY26 shows income near ₹97 crore with losses on both consolidated and standalone bases. The second is compliance and capital actions, where repeated disclosures around trading-window closure, board meeting schedules, and newspaper publications reflect ongoing reporting milestones.

For investors and market observers, the next trackable items are procedural: shareholder voting outcomes for the postal ballot resolutions and future exchange updates related to financial results disclosures. The dataset also references submissions for the period ended March 31, 2026, but it does not provide financial figures for that period.

Conclusion

Vikas Lifecare’s disclosed Q3 FY26 unaudited numbers showed lower income versus Q2 FY26 and continued losses, while the company completed required publication and exchange-filing steps under SEBI regulations. Alongside the results, the postal ballot proposals on warrants issuance and authorised capital increase add a corporate action angle that investors will likely monitor through subsequent exchange updates and voting outcomes.